Hudson Yards getting set for its grand opening – The Villager | The Villager — Read on www.thevillager.com/2019/02/hudson-yards-getting-set-for-its-grand-opening/
Who is an augmented researcher? Scholarly publishing has changed considerably in recent years. Perhaps the biggest transformation is one we now take for granted – the move to digital. — Read on www.rdmag.com/article/2018/01/augmented-researcher-what-does-2018-hold-ai-publishing
The EPO Annual Report 2018 is out. Demand for patent protection reaches a new high: 4.6% growth in applications filed and 21% more European patents granted. — Read more: https://www.epo.org/about-us/annual-reports-statistics/annual-report/2018.html
PolyAI, a London, UK-based platform for conversational artificial intelligence, raised $12m in Series A funding. — Read more: www.finsmes.com/2019/03/polyai-raises-12m-in-series-a-funding.html
The Bill and Melinda Gates Foundation published their annual letter that highlights the surprises they saw in 2018. Among many other compelling facts, the letter pointed out one surprise that seems to be of particular interest: the median age of the African continent is just 18 years old.— Re...
What is the current ranking for the top most-visited cities in the world?
Easy but important steps to learn new language and have fun. www.ted.com/talks/lydia_machova_the_secrets_of_learning_a_new_language
The combined company will have nine products with more than $1 billion in annual sales and significant potential for growth in oncology, immunology and inflammation and cardiovascular disease. — Read on www.cnbc.com/2019/01/03/bristol-myers-to-buy-celgene-in-a-74-billion-deal.html
The world in 2030. A Global Research article discussing the fast growth of China and India’s economies. — Read on www.gbm.hsbc.com/insights/growth/the-world-in-2030
New prescription drug-use related software proposed by FDA will help companies and develop an efficient pathway to help increase safety and effectiveness. Read on: www.natlawreview.com/article/significant-fda-digital-health-policy-development-prescription-drug-sponsors